ÂÜÀòÂÒÂ×

Carmen Miravet Zaragoza holds a diverse background in the medical and scientific fields, currently serving as a Medical Science Liaison at QIAGEN since April 2022, where responsibilities include syndromic testing and overseeing clinical studies across the European Union. Previously, roles at FAES FARMA and GSK involved positions as a Medical Advisor, with a focus on infectious diseases as part of the HIV Medical Team at ViiV Healthcare. Notably, Carmen conducted clinical immuno-oncology research at Imperial College London, specializing in Glioblastoma, while holding an MSc in Immunology from the same institution. Additional qualifications include a Certificate of Achievement in Immuno-oncology from Harvard Medical School and a BSc in Biomedical Sciences from Edinburgh Napier University.